Intermediate-term results of REGROUP trial extend earlier findings
Study suggests carotid disease might just be a marker of atherosclerotic burden
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy